Women who work at night may raise cancer risk
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Women who work at night may be exposing themselves to an increased risk of breast cancer, say scientists who believe there could be a link to underproduction of melatonin, the brain's sleep chemical.
George Brainard, professor of neurology at the Thomas Jefferson University in Philadelphia, told the association there was mounting evidence to suggest that suppression of melatonin production in the body by exposure to bright, night-time light could be linked with breast cancer.
Melatonin is influenced by the intensity of light entering the eye and is a key component of the complex mechanism that controls the body's circadian clock, which it is why some travellers take it as a treatment for jet lag.
Professor Brainard said melatonin inhibited the growth of some cancer cells in the test-tube, and studies on animals had shown that suppressing melatonin by exposure to bright light at night increased the growth of tumours.
In humans, he said, epidemiological studies have shown that women who work night shifts over many years have an increased risk of breast cancer, and other researchers have shown a lower risk of breast cancer in blind women whose melatonin production is unaffected by night-time light.
Light can heal, and harm. It can help people suffering from seasonal affective disorder caused by long winter nights but it may also harm others because it induces an underproduction of melatonin, he said.
"In the long range, we think this will shape all artificial lighting, whether it's used for therapeutic purposes, or for normal illumination of workplaces, hospitals or homes," Professor Brainard said. "Broad changes in general architectural lighting may take years, but the groundwork has been established."
The exact mechanism that could implicate melatonin in suppressing breast cancer was still unresolved, he added.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments